Home > Income Statement > MANGALAM DRUGS AND ORGANICS

MANGALAM DRUGS AND ORGANICS
Revenue

    Back to Income Statement
MANGALAM DRUGS AND ORGANICS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for MANGALAM DRUGS AND ORGANICS
Please provide your vote to see the results

MANGALAM DRUGS AND ORGANICS Last 5 Year Revenue History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
Net Sales ₹451 Cr₹385 Cr₹282 Cr₹228 Cr₹279 Cr

What is the latest Revenue of MANGALAM DRUGS AND ORGANICS ?

The latest Revenue ratio of MANGALAM DRUGS AND ORGANICS is ₹451 Cr based on Mar2023 Standalone results.
Year Revenue
Mar2023₹451 Cr
Mar2022₹385 Cr
Mar2021₹282 Cr
Mar2020₹228 Cr
Mar2019₹279 Cr

How is Revenue of MANGALAM DRUGS AND ORGANICS Trending?

Years Revenue % Change
Mar2023 ₹451 Cr
17.25
Mar2022 ₹385 Cr
36.25
Mar2021 ₹282 Cr
24.07
Mar2020 ₹228 Cr
-18.54
Mar2019 ₹279 Cr -

Compare Revenue of peers of MANGALAM DRUGS AND ORGANICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANGALAM DRUGS AND ORGANICS ₹161.6 Cr 1.5% 10.4% -10.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹364,315.0 Cr -0.1% -6.3% 53.5% Stock Analytics
CIPLA ₹114,614.0 Cr 1% -5% 53.3% Stock Analytics
DIVIS LABORATORIES ₹105,233.0 Cr 3.2% 15.3% 23.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,900.0 Cr 1.1% 2.2% 26% Stock Analytics
ZYDUS LIFESCIENCES ₹99,426.0 Cr 3.9% -1.7% 85.2% Stock Analytics


MANGALAM DRUGS AND ORGANICS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANGALAM DRUGS AND ORGANICS

1.5%

10.4%

-10.9%

SENSEX

1%

2.2%

23.7%


You may also like the below Video Courses